TERCICA
Tercica Inc., a biotechnology company, engages in the development and commercialization of therapeutics for the treatment of endocrine and metabolic diseases. Its products include Increlex, an rDNA origin injection for the long-term treatment of children with short stature due to severe primary IGFD; and Somatuline Depot, a lanreotide injection for the treatment of adults with acromegaly. Tercica Inc. has strategic partnerships with Genentech and Ipsen SA. The company was founded in 2002 and is based in Brisbane, California. As of October 16, 2008, Tercica Inc. operates as a subsidiary of Ipsen S.A.
TERCICA
Industry:
Biotechnology Children Pharmaceutical
Founded:
2000-01-01
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.ipsenus.com
Total Employee:
501+
Status:
Active
Contact:
9082756301
Email Addresses:
[email protected]
Total Funding:
148.5 M USD
Technology used in webpage:
Amazon Amazon Route 53 Amazon CloudFront Vimeo Vimeo CDN
Similar Organizations
![]()
Alnara Pharmaceuticals
Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
![]()
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
![]()
MYR GmbH
MYR is a biotechnology company developing and commercilizing therapeutics for the treatment of chronic hepatitis B and D infections.
Current Advisors List
![]()
![]()
![]()
Stock Details
Investors List

GenenFUND
GenenFUND investment in Post-IPO Equity - Tercica
![]()
Kingsbridge Capital
Kingsbridge Capital investment in Post-IPO Equity - Tercica
![]()
Care Capital
Care Capital investment in Series B - Tercica
MPM Capital
MPM Capital investment in Series B - Tercica
![]()
Prospect Venture Partners
Prospect Venture Partners investment in Series B - Tercica
![]()
Rho Ventures
Rho Ventures investment in Series B - Tercica
![]()
MedImmune Ventures
MedImmune Ventures investment in Series B - Tercica
![]()
Genentech
Genentech investment in Series A - Tercica
Official Site Inspections
http://www.ipsenus.com
- Host name: server-3-167-112-97.iad55.r.cloudfront.net
- IP address: 3.167.112.97
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
